Neonatal Opioid Withdrawal Syndrome

被引：2
|
作者：
Easterlin, Molly Crimmins [1 ]
Ramanathan, Rangasamy [2 ,3 ,4 ,5 ,6 ,7 ]
De Beritto, Theodore [8 ]
机构：
[1] Univ Southern Calif, Div Neonatol, Dept Pediat, LAC USC Med Ctr,Keck Sch Med, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Div Neonatal Med, LAC USC Med Ctr, Los Angeles, CA 90007 USA
[3] Univ Southern Calif, PIH Good Samaritan Hosp, Los Angeles, CA 90007 USA
[4] Univ Southern Calif, Neonatal Perinatal Med Fellowship, Los Angeles, CA 90007 USA
[5] Univ Southern Calif, NICU, LAC USC Med Ctr, Los Angeles, CA 90007 USA
[6] Univ Southern Calif, Neonatal Hemodynam Program, LAC USC Med Ctr, Keck Sch Med, Los Angeles, CA 90007 USA
[7] Univ Southern Calif, Neonatal Resp Therapy Serv, LAC USC Med Ctr, Keck Sch Med, Los Angeles, CA 90007 USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Pediat, Div Neonatol,Dept Pediat,Mattel Childrens Hosp, Los Angeles, CA 90095 USA
来源：
PEDIATRIC ANNALS | 2022年 / 51卷 / 06期
关键词：
ABSTINENCE SYNDROME; UNITED-STATES; USE DISORDER; BUPRENORPHINE; ASSOCIATION; METHADONE; PROTOCOL;
D O I：
10.3928/19382359-20220407-05
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Opioid use, both prescribed and illicit, has grown exponentially in the United States since the late 1990s, and with it, opioid use during pregnancy and neonatal abstinence syndrome (NAS) have also increased. NAS is a withdrawal syndrome occurring in newborns that results from maternal opioid use during pregnancy and has variable onset, severity, and duration. Given the increasing incidence of NAS, this article seeks to review its definition, presentation, evaluation, and management to ensure adequate care of these infants and families.
引用
收藏
页码：E234 / E242
页数：9
相关论文
共 50 条
  • [31] The imperative of clinical and molecular research on neonatal opioid withdrawal syndrome
    Raghu P. Metpally
    Sarath Krishnamurthy
    Karena M. Moran
    Andrew E. Weller
    Richard C. Crist
    Benjamin C. Reiner
    Glenn A. Doyle
    Thomas N. Ferraro
    Uppala Radhakrishna
    Ray Bahado-Singh
    Vanessa Troiani
    Wade H. Berrettini
    Molecular Psychiatry, 2019, 24 : 1568 - 1571
  • [32] Neonatal head circumference in opioid-exposed neonates with and without Neonatal Opioid Withdrawal Syndrome (NOWS)
    Johnson, Quinetta
    O'Brien, John
    Hawk, Greg
    Qi, Ya
    Critchfield, Agatha
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S250 - S250
  • [33] Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome
    Bhatt-Mehta, Varsha
    Jing, Xinyue
    Wang, Xinwen
    Zhu, Hao-Jie
    PHARMACOTHERAPY, 2024, 44 (01): : 22 - 27
  • [34] Enhancing Care for Parents of Infants with Neonatal Opioid Withdrawal Syndrome
    Garcia, Andrea
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2024, 49 : 38 - 39
  • [35] The imperative of clinical and molecular research on neonatal opioid withdrawal syndrome
    Metpally, Raghu P.
    Krishnamurthy, Sarath
    Moran, Karena M.
    Weller, Andrew E.
    Crist, Richard C.
    Reiner, Benjamin C.
    Doyle, Glenn A.
    Ferraro, Thomas N.
    Radhakrishna, Uppala
    Bahado-Singh, Ray
    Troiani, Vanessa
    Berrettini, Wade H.
    MOLECULAR PSYCHIATRY, 2019, 24 (11) : 1568 - 1571
  • [36] Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy
    Morrison, Tierney M.
    MacMillan, Kathryn Dee L.
    Melvin, Patrice
    Singh, Rachana
    Murzycki, Jennifer
    Van Vleet, Marcia W.
    Rothstein, Robert
    O'Shea, Thomas F.
    Gupta, Munish
    Schiff, Davida M.
    Wachman, Elisha M.
    HOSPITAL PEDIATRICS, 2022, 12 (05)
  • [37] Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics
    van Hoogdalem, Matthijs W.
    McPhail, Brooks T.
    Hahn, David
    Wexelblatt, Scott L.
    Akinbi, Henry T.
    Vinks, Alexander A.
    Mizuno, Tomoyuki
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (01) : 87 - 103
  • [38] BuprenorphineSomnolence and neonatal opioid withdrawal syndrome: 2 case reports
    Reactions Weekly, 2023, 1976 (1) : 86 - 86
  • [39] Clonidine as Monotherapy for Neonatal Opioid Withdrawal Syndrome: A Randomized Trial
    Bada, Henrietta S.
    Westgate, Philip M.
    Sithisarn, Thitinart
    Yolton, Kimberly
    Charnigo, Richard
    Pourcyrous, Massroor
    Tang, Fei
    Gibson, Julia
    Shearer-Miller, Jennifer
    Giannone, Peter
    Leggas, Markos
    PEDIATRICS, 2024, 154 (05)
  • [40] Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
    Tobacyk, Julia
    Parks, Brian J.
    Salazar, Paloma
    Coward, Lori U.
    Berquist, Michael D.
    Gorman, Gregory S.
    Brents, Lisa K.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 249
12345